BayBG news

BayBG invests 37,8 million euros in Bavarian SMEs and startups, supporting innovation and growth in 2026.

The latest annual report provides a concise overview of the key developments, figures and strategic actions in the 2024/25 financial year.

BayBG announces a management transition: Stefan Koller joins as Managing Director as of April 1, 2026. Together with long-standing CFO Andreas Käufl and CEO Peter Pauli, he will form a three-member leadership team.

What businesses can learn from aviation: Nicola Winter shared insights on making decisions under pressure and applying them to crisis situations.

BayBG Venture Capital successfully exits AMW, a specialty pharma company for biodegradable drug delivery systems. Ren Life Sciences and Juno Capital Partners become new majority shareholders as AMW enters its next growth phase.

BayBG is joining IBEX Wachstumspartner as a co-investor in the ERP and HR software specialist Softfolio.